Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-08-19 4:34 pm Purchase | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 9,192,814 19.99% | 5,732,463 (+165.66%) | View |
| 2022-06-21 10:04 am Purchase | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 15,230,473 19.99% | 15,230,473 (New Position) | View |
| 2022-04-21 10:00 am Purchase | 13G | TREVI THERAPEUTICS INC TRVI | Fairmount Funds Management LLC | 3,759,510 9.9% | 3,759,510 (New Position) | View |
| 2022-04-21 10:00 am Purchase | 13G | ANNEXON INC ANNX | Fairmount Funds Management LLC | 2,569,400 6.7% | 2,569,400 (New Position) | View |
| 2022-02-11 1:26 pm Purchase | 13G | OLEMA PHARMACEUTICALS INC OLMA | Fairmount Funds Management LLC | 2,107,873 5.2% | 2,107,873 (New Position) | View |
| 2022-02-08 4:31 pm Sale | 13G | ASTRIA THERAPEUTICS INC ATXS | Fairmount Funds Management LLC | 911,736 7% | -62,869 (-6.45%) | View |
| 2021-09-23 4:31 pm Purchase | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 3,460,351 19.99% | 3,460,351 (New Position) | View |
| 2021-09-22 3:57 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Fairmount Funds Management LLC | 974,605 7.6% | 974,605 (New Position) | View |
| 2021-06-17 1:32 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Fairmount Funds Management LLC | 4,092,166 5.3% | 4,092,166 (New Position) | View |
| 2021-01-05 06:04 am Purchase | 13D | MIRAGEN THERAPEUTICS INC MGEN | Fairmount Funds Management LLC | 967,671 19.99% | 967,671 (New Position) | View |
| 2020-07-09 5:32 pm Purchase | 13D | UNUM THERAPEUTICS INC UMRX | Fairmount Funds Management LLC | 7,482,460 19.99% | 7,482,460 (New Position) | View |